Last reviewed · How we verify

NCT03116646

The Reliability and Validity of Family Report Chewing Evaluation

Completed NA Last updated 2 June 2020
What this trial tests

NA trial testing Chewing evaluation in Mastication Disorder in 60 participants. Completed in 20 November 2019.

Timeline
15 March 2019
Primary endpoint
20 November 2019
20 November 2019

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date15 March 2019
Primary completion20 November 2019
Estimated completion20 November 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 Months to 18, any sex, with Mastication Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The family has a primary prescription in the identification of the chewing disorder in children to plan appropriate rehabilitation program and implementation of the training. Therefore, it is very important to investigate the validity and reliability of classification systems that can be applied by parents. The purpose of this study is to determine the validity and reliability of the reliability and validity of family report chewing evaluation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Chewing evaluation

Trials testing the same drug.

Other recruiting trials for Mastication Disorder

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03116646.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing